Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
University of Oxford
Pharma
Novo Nordisk's Ozempic cuts dementia risk vs. Merck's Januvia
A study from the University of Oxford indicates that Novo's Ozempic can reduce the risk of dementia compared with another popular diabetes medicine.
Kevin Dunleavy
Jul 12, 2024 10:14am
SII ships first doses of Oxford, Novavax-partnered malaria shot
May 20, 2024 4:19pm
Social media influencers celebrate new malaria shot
Oct 9, 2023 11:18am
Ghana first to approve University of Oxford's malaria vaccine
Apr 14, 2023 11:51am
AstraZeneca consortium gets cash for nucleic acid delivery work
Jan 24, 2023 6:30am
